ClinicalTrials.gg
Active, not recruitingNCT05770089APAREXIM-PUpdated Jul 23, 2025

Videoconferencing Adapted Physical Activity in Anorexia Nervosa: a Pilot Study

An interventional study of Adapted Physical Activity (APA) in Anorexia Nervosa, Exercise Therapy and Videoconferencing, sponsored by University Hospital, Caen. Active, not recruiting at 1 site in France. Open to female participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-23.

Sponsored by University Hospital, Caen · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
13 Years to 18 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Anorexia Nervosa with a site in France — 16 open to participants now, 21 under way, 1 of them phase 3. Anorexia Nervosa · France.

Planned enrollment
35th of 48
30 · median 56
Started
2022
with 4 others
No phase
45 of 79
8 open now
Primary completion
2026-12
later than 5 of 20 live
Registered
62nd of 79
by date

Among the 79 studies in Anorexia Nervosa with a site in France, this one is the 35th largest by planned enrollment of the 48 interventional ones that give a count, is one of 5 that started in 2022, is one of 45 with no phase, reaches primary completion later than 5 of the 20 other live ones, and was the 62nd registered.

Anorexia Nervosa

471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.

Browse Anorexia Nervosa studies →

Open to participants now

16 of the 79 studies in Anorexia Nervosa with a site in France are open now. Recruiting first, the newest first:

11 more — sign in →

All 16 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.

This study: 13 Years to 18 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Anorexia Nervosa with a site in France, or all of them as a file.
02

Study summary

The primary objectives of the APAREXIM'Pilot study are to evaluate the short- and medium-term effects of a live supervised Adapted Physical Activity (APA) program via videoconferencing on:

  • Feasibility and acceptability of APA via videoconferencing by the patients.
  • The primary symptoms of Anorexia Nervosa (AN).

The secondary objectives are to evaluate the impact of this program on :

  • Mental health
  • Physical condition
  • Sleep-wake cycle (sleep disturbance and physical hyperactivity)

The patients will first undergo an inclusion visit (T0) at the University Hospital of Caen, then a first evaluation session (T1) at the COMETE laboratory in Caen (physical tests, questionnaires, sleep diary, actimetry). They will then be randomly divided into 2 groups: 15 patients who will follow an APA program supervised by videoconference for 8 weeks (AM-APA) at their home, in addition to the usual outpatient treatment, and 15 patients who will benefit only from the classic outpatient treatment (AM-T). All patients will undergo two additional evaluation sessions at one week post-program (T2) and at 3 months post-program (T3).

Read the detailed description

Background: Anorexia nervosa (AN) is an eating disorder (ED), mainly in women, characterized by strict and voluntary food deprivation over a long period of time, which can last from several months to several years, leading to significant weight loss. This disease affects 2.2 to 4% of the general population in Europe and is one of the most fatal psychiatric diseases in people under 25 years old. Physiological and psychological disorders are very often associated with AN, as well as an alteration of the sleep-wake cycle. In order to reduce the risk of chronicity of the disease and to prevent its various complications in young women, early and multidisciplinary therapeutic management is recommended by public health authorities. However, this management remains long and complex due to the diversity and severity of the symptoms, a lack of adherence of patients to treatment protocols, but also a lack of therapeutic continuity after hospitalization. Recently, new non-medicinal therapies based on Adapted Physical Activity (APA) have been developed to prevent and reduce the main symptoms of AN and associated disorders in an effective and lasting way. However, to our knowledge, interventional research in this field remains scarce and presents limited results. Furthermore, the scientific literature does not report any evaluation of the feasibility, acceptability, and effectiveness of a home video-conference-supervised APA intervention with AN patients.

Objectives: The primary objectives of the APAREXIM'Pilot study are to evaluate the short- and medium-term effects of a live supervised APA program via videoconferencing on feasibility and acceptability of APA via videoconferencing by the patients and the primary symptoms of AN. The secondary objectives are to evaluate the impact of this program on mental health, physical condition and the sleep-wake cycle (sleep disturbance and physical hyperactivity), as well as its.

Method: This randomized controlled intervention study will be conducted with 30 adolescent and young adult girls with AN. The patients will first undergo an inclusion visit (T0) at the University Hospital of Caen, then a first evaluation session (T1) at the COMETE laboratory in Caen (physical tests, questionnaires, sleep diary, actimetry). They will then be randomly divided into 2 groups: 15 patients who will follow an APA program supervised by videoconference for 8 weeks (AM-APA) at their home, in addition to the usual outpatient treatment, and 15 patients who will benefit only from the classic outpatient treatment (AM-T). All patients will undergo two additional evaluation sessions at one week post-program (T2) and at 3 months post-program (T3).

Perspectives: The results obtained will allow to evaluate the acceptability and the feasibility of a distance APA program, and to bring additional evidence of the effectiveness of an APA intervention in patients with AM, as well as elements of understanding of the regulation of this pathology by APA. In addition, the APAREXIM'Pilot study will allow to test and validate an APA program for patients with AM, which could eventually be integrated in the management of patients on the national territory.

03

Conditions studied

  • Anorexia Nervosa
  • Exercise Therapy
  • Videoconferencing

Keywords

  • eating disorders
  • anorexia nervosa
  • physical activity
  • exercise
  • psychiatry
  • mental health
  • muscle strength
  • chronobiology
  • physical condition
  • adolescent
  • pediatric
  • videoconferencing
04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patient between 13 and 18 years old, with typical anorexia nervosa symptoms diagnosed by a specialist.
  • Patient followed in outpatient care.
  • Collection of the signature of the .
  • Patient affiliated to the health insurance system.
  • Agreement of the legal representatives

Exclusion criteria

Exclusion Criteria:

  • Patient with to physical activity or with a state of health judged critical by the doctor.
  • Person deprived of liberty by judicial or administrative decision, or under guardianship or curatorship.
  • Pregnant or breast-feeding woman.
  • Patient included in another biomedical research protocol during the present study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    AM-APA

    The group following the Adapted Physical Activity program via videoconferencing in addition to the outpatient care.

    Other: Adapted Physical Activity (APA)

  • No intervention
    AM-T

    The group without additional intervention other than the outpatient care.

Interventions

  • OtherAdapted Physical Activity (APA)

    A 8-weeks program of APA (2x1hour per week) via videoconferencing composed of resistance training and yoga.

    Also known as: Interventional exercise therapy

06

What researchers measure

Primary outcomes

  1. Treatment Acceptability and Preferences questionnaire (TAP-Q)

    Questionnaire (scale) assessing the acceptability of the APA program via videoconferencing (high score mean better outcome).

    Time frame: T2 (just after the APA program)

  2. Eating Attitude Test - 26 (EAT-26)

    Questionnaire (scale) assessing the severity of main anorexic symptoms (high score mean worse outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

Secondary outcomes

  1. Hospital Anxiety and Depression (HAD) scale

    Questionnaire (scale) assessing anxious and depressive symptoms (high score mean worse outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  2. Rosenberg Self-esteem Scale (RSS)

    Questionnaire (scale) assessing self-esteem (high score mean better outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  3. Contour Drawing Rating Scale (CDRS)

    Questionnaire (scale) assessing self-esteem (high score mean worse outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  4. Body Esteem Scale (BES)

    Questionnaire (scale) assessing body esteem (high score mean better outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  5. Exercise Dependence Scale Revised

    Questionnaire (scale) assessing exercise dependence (high score mean worse outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  6. Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Questionnaire (scale) assessing interoceptive awareness (high score mean better outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  7. Pittsburgh Sleep Quality Index (PSQI)

    Questionnaire (scale) assessing sleep quality (high score mean worse outcome).

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  8. Actimetry

    One week of actimetry with an accelerometer watch measuring 7x24h activity counts allowing to extract day and night activity level.

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  9. Body Mass Index (BMI)

    Measure of body weight and height to compute the BMI

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  10. Body composition - Body cellular mass

    Bio-impedance measuring of body cellular mass

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  11. Body composition - Fat mass

    Bio-impedance measuring of body fat mass

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  12. Body composition - Fat free mass

    Bio-impedance measuring of body fat-free mass

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  13. Body composition - Total body water

    Bio-impedance measuring of total body water

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  14. Body composition - Extracellular water

    Bio-impedance measuring of body extracellular water

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  15. Isokinetic assessment of upper and lower limbs

    Isokinetic peak torque (concentric contraction at 60°/sec and 240°/sec) of forearm and leg flexion/extension.

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  16. Back extension strength

    Assessment of the back extension strength with a dynamometer

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  17. Shirado test

    Assessment of the isometric back flexion endurance with the Shirado test

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

  18. Sorensen test

    Assessment of the isometric back extension endurance with the Sorensen test

    Time frame: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Dec 2026, 48 months after the start.

Of 149 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 48 months is above that.

Counting every sponsor, half of 149 studies reached it within 43 months; a quarter within 24 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2022
First posted
Mar 15, 2023
StartActual
Dec 1, 2022
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Jul 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05770089
Responsible party
Sponsor
First posted
Mar 15, 2023
Start date
Dec 1, 2022
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jul 23, 2025

Study contacts

Fabian GUENOLE, MD PhD Pr
principal investigator · Caen Hospital University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion